论文信息 - A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results - 字舞流文

A Phase 2 Study Of Lenalidomide, Rituximab, Cyclophosphamide and Dexamethasone (LR-CD) For Untreated Low Grade Non-Hodgkin Lymphoma Requiring Therapy: Waldenström’s Macroglobulinemia Cohort Results

Macp | Chb | T. Habermann | R. Fonseca | D. Dingli | S. Ansell | Shaji K. Kumar | S. Russell | A. Dueck | C. Reeder | M. Gertz | T. Witzig | R. Tiedemann | F. Buadi | P. Kapoor | N. Leung | G. Nowakowski | D. Inwards | J. Mikhael | J. Leis | P. Noel | J. Colgan | J. Camoriano | J. Slack | C. Conley | L. Porrata | K. Gano | K. Curtis | K. Stewart | R. Valdez